Gland Pharma Ltd - 543245 - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025

Gland Pharma Ltd.

NSE: GLAND | BSE: 543245 | ISIN: INE068V01023 | Industry: Pharmaceuticals
| Mid-range Performer

1898.6000 -13.20 (-0.69%)

NSE Nov 06, 2025 15:31 PM

Volume: 99,824

Gland Pharma Ltd.

03 Nov 2025

1898.60

-0.69%

Result

BSE India

Unaudited Financial Results for the quarter and half year ended September 30, 2025

	Sep 2025	Jun 2025	Sep 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	1571.04	1563.15	1465.49	0.5%	7.2%
Operating Profit Qtr	313.89	367.76	297.06	-14.6%	5.7%
Net Profit Qtr	183.68	215.48	163.53	-14.8%	12.3%
Earning Per Share Adjusted latest Qtr	11.15	13.08	9.93	-14.8%	12.3%

* Consolidated data

Detailed Results